HARBOR CAPITAL ADVISORS, INC. - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 148 filers reported holding ROCKET PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
HARBOR CAPITAL ADVISORS, INC. ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2023$1,629,019
+38.7%
54,355
-5.2%
0.31%
+24.7%
Q3 2023$1,174,425
+6.9%
57,317
+3.7%
0.25%
+14.1%
Q2 2023$1,098,453
+20.4%
55,282
+3.8%
0.22%
-16.3%
Q1 2023$912,566
-28.3%
53,273
-18.1%
0.26%
-78.7%
Q4 2022$1,272,226
+20.0%
65,009
-2.1%
1.23%
+26.8%
Q3 2022$1,060,000
+4.4%
66,410
-9.9%
0.97%
+26.0%
Q2 2022$1,015,000
-14.8%
73,743
-1.9%
0.77%
+37.4%
Q1 2022$1,192,000
-38.2%
75,177
-14.9%
0.56%
-19.9%
Q4 2021$1,929,00088,3850.70%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 16,812,491$234,534,00010.10%
TANG CAPITAL MANAGEMENT LLC 2,965,485$41,369,0005.81%
Ghost Tree Capital, LLC 650,000$9,068,0002.40%
Boxer Capital, LLC 1,466,051$20,451,0001.39%
Vivo Capital, LLC 860,648$12,006,0001.09%
Samsara BioCapital, LLC 128,197$1,788,0001.03%
Cormorant Asset Management, LP 1,568,550$21,881,0001.02%
Perceptive Advisors 2,189,010$30,537,0000.80%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,677,367$23,399,0000.74%
Eventide Asset Management 1,415,000$19,739,0000.64%
View complete list of ROCKET PHARMACEUTICALS INC shareholders